These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2556795)

  • 1. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.
    Viscidi RP; Mayur K; Lederman HM; Frankel AD
    Science; 1989 Dec; 246(4937):1606-8. PubMed ID: 2556795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.
    Dis Markers; 1990; 8(4):220. PubMed ID: 2088639
    [No Abstract]   [Full Text] [Related]  

  • 3. Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes.
    Zauli G; Gibellini D; Celeghini C; Mischiati C; Bassini A; La Placa M; Capitani S
    J Immunol; 1996 Sep; 157(5):2216-24. PubMed ID: 8757349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effect on lymphocytes of Tat from human immunodeficiency virus (HIV-1).
    Benjouad A; Mabrouk K; Moulard M; Gluckman JC; Rochat H; Van Rietschoten J; Sabatier JM
    FEBS Lett; 1993 Mar; 319(1-2):119-24. PubMed ID: 8095908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1.
    Frankel AD; Biancalana S; Hudson D
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7397-401. PubMed ID: 2552444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
    Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S
    Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helper T-cell recognition of HIV-1 Tat synthetic peptides.
    Blazevic V; Ranki A; Mattinen S; Valle SL; Koskimies S; Jung G; Krohn KJ
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):881-90. PubMed ID: 7686223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
    Southgate C; Zapp ML; Green MR
    Nature; 1990 Jun; 345(6276):640-2. PubMed ID: 2190099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA immunization with HIV-1 tat mutated in the trans activation domain induces humoral and cellular immune responses against wild-type Tat.
    Caselli E; Betti M; Grossi MP; Balboni PG; Rossi C; Boarini C; Cafaro A; Barbanti-Brodano G; Ensoli B; Caputo A
    J Immunol; 1999 May; 162(9):5631-8. PubMed ID: 10228047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nonapeptides derived from the N-terminal structure of human immunodeficiency virus-1 (HIV-1) Tat on suppression of CD26-dependent T cell growth.
    Wrenger S; Reinhold D; Faust J; Mrestani-Klaus C; Brandt W; Fengler A; Neubert K; Ansorge S
    Adv Exp Med Biol; 2000; 477():161-5. PubMed ID: 10849743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV type 1 Tat protein enhances activation-but not Fas (CD95)-induced peripheral blood T cell apoptosis in healthy individuals.
    Katsikis PD; García-Ojeda ME; Torres-Roca JF; Greenwald DR; Herzenberg LA; Herzenberg LA
    Int Immunol; 1997 Jun; 9(6):835-41. PubMed ID: 9199966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.
    Zagury D; Lachgar A; Chams V; Fall LS; Bernard J; Zagury JF; Bizzini B; Gringeri A; Santagostino E; Rappaport J; Feldman M; Burny A; Gallo RC
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3851-6. PubMed ID: 9520456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zn2+ binding to cysteine-rich domain of extracellular human immunodeficiency virus type 1 Tat protein is associated with Tat protein-induced apoptosis.
    Misumi S; Takamune N; Ohtsubo Y; Waniguchi K; Shoji S
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):297-304. PubMed ID: 15117453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells.
    Westendorp MO; Li-Weber M; Frank RW; Krammer PH
    J Virol; 1994 Jul; 68(7):4177-85. PubMed ID: 8207793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 gp41 selectively inhibits spontaneous cell proliferation of human cell lines and mitogen- and recall antigen-induced lymphocyte proliferation.
    Chen YH; Christiansen A; Dierich MP
    Immunol Lett; 1995 Nov; 48(1):39-44. PubMed ID: 8847089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses.
    Fanales-Belasio E; Moretti S; Nappi F; Barillari G; Micheletti F; Cafaro A; Ensoli B
    J Immunol; 2002 Jan; 168(1):197-206. PubMed ID: 11751963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of HIV-1 Tat protein on human T cell proliferation.
    Meyaard L; Otto SA; Schuitemaker H; Miedema F
    Eur J Immunol; 1992 Oct; 22(10):2729-32. PubMed ID: 1396975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigen.
    Moreau E; Hoebeke J; Zagury D; Muller S; Desgranges C
    J Virol; 2004 Apr; 78(7):3792-6. PubMed ID: 15016898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
    Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA
    Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.